AstraZeneca drug approved by FDA for kidney disease treatment
May 4, 2021Manufacturing and Production AstraZeneca, FDA, kidney disease, pharma, pharma news
AstraZeneca’s Farxiga drug has been approved for the treatment of chronic kidney disease (CKD) in the US by the FDA.
NICE finds more SMA patients eligible for £75,000 a vial drug
May 4, 2021Manufacturing and Production, Sales and Marketing NICE, sma
NICE has announced that more people with the rare genetic disorder spinal muscular atrophy (SMA) are to benefit from nusinersen, …
Novartis eye treatment for diabetics shows positive results in Phase III trial
May 4, 2021Manufacturing and Production DME, Novartis, diabetic macular edema, macular edema, pharma, pharma news
Novartis’ Beovu treatment for diabetic macular edema (DME) – an eye condition that can cause blindness – has shown positive …
Needle-free pandemic influenza vaccine sees preclinical proof-of-concept
May 4, 2021Manufacturing and Production, Sales and Marketing Vaccine technology
Enesi Pharma, a US biotechnology company developing novel vaccination products, announced the development of a solid-dose recombinant H7N9 pandemic influenza …
Moderna to supply up to 500 million COVID-19 vaccines to COVAX
May 4, 2021Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO
Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …
Pharmafile.com’s top 10 news stories of the week
April 30, 2021Medical Communications COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news
Among our top 10 stories this week: In COVID news, an app has revealed the most common side effects for …
Celltrion’s COVID-19 treatment shows promise against South African variant
April 30, 2021Medical Communications COVID-19, celltrion, covid 19 news, covid-19 news, covid-19 treatment, pharma, pharma news
Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according …
Melanoma market to reach $7.4bn by 2029
April 30, 2021Medical Communications melanoma
A report from GlobalData, Melanoma – Global Drug Forecast and Market Analysis to 2029, has predicted the melanoma industry will …
Scipher Medicine to expand into autoimmune disease therapeutics
April 30, 2021Medical Communications AI, autoimmune diseases
Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …
Positive phase III results achieved for dialysis drug in China
April 30, 2021Medical Communications China, Kideny disease
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced positive results from a phase-III study in China (PA-CL-CHINA-01), evaluating the …
Takeda’s lung cancer drug granted FDA priority review
April 29, 2021FDA, Takeda, lung cancer treatment, pharma, pharma news
The FDA has granted priority review for Takeda’s New Drug Application (NDA) for its mobocertinib drug for the treatment of …
Pharnext CMT drug shows positive Phase III results
April 29, 2021CMT, Charcot-Marie-Tooth Disease, Phase III trial, pharma, pharma news, pharnext
Pharnext SA’s PXT3003 treatment for patients with Charcot-Marie-Tooth Disease (CMT) has shown positive interim results in its ongoing Phase III …
EC approves Kaftrio as combination treatment for cystic fibrosis
April 29, 2021EU, European Commission, cystic fibrosis
Vertex Pharmaceuticals has been granted European Commission approval for the label extension of Kaftrio (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with …
Bristol Myers Squibb psoriasis drug shows positive Phase III results
April 29, 2021Bristol-Myers Squibb, bristol myers squibb, pharma, pharma news, psoriasis, psoriasis treatment
Bristol Myers Squibb’s investigational deucravacitinib drug, for the treatment of moderate-to-severe plaque psoriasis, has shown positive results in two Phase …
Moderna up investments to produce 3 billion COVID vaccine doses in 2022
April 29, 2021COVID-19, Moderna, Vaccine, investment
Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …
Pharmafile.com’s weekly COVID-19 news round-up
April 28, 2021Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news
The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …
COVID Symptom Study app reveals most common vaccine side effects
April 28, 2021Research and Development COVID-19, Vaccine, data
An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …
Calliditas’ kidney disease drug granted priority review by FDA
April 28, 2021Research and Development Calliditas, FDA, nephropathy, pharma, pharma news
The FDA has granted priority review for the New Drug Applicaton (NDA) for Calliditas Therapeutics’ Nefecon, for the treatment of …
NICE to join GetReal Institute alongside nine key healthcare players
April 28, 2021Research and Development EU, NICE, rwe
NICE has announced it will join with nine other organisations to form the GetReal Institute, a not-for-profit multi-stakeholder enterprise, as …
Single dose of COVID vaccine can cut transmissions in half
April 28, 2021Research and Development COVID-19, Public Health England, Vaccine
A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
